No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer’s Disease: A Randomised Controlled Trial

International Journal of Molecular Sciences - Tập 16 Số 10 - Trang 24600-24613
Michelle Phillips1, Caroline E. Childs2, Philip C. Calder2,3, Peter J. Rogers1
1School of Experimental Psychology, University of Bristol, Bristol, BS8 1TU, UK
2Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton, SO16 6YD, UK
3NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and University of Southampton, Southampton, SO16 6YD, UK

Tóm tắt

Findings from epidemiological and observational studies have indicated that diets high in omega-3 polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) may reduce the risk of cognitive decline and Alzheimer’s disease (AD). To determine if increasing intake of DHA and EPA through supplementation is beneficial to cognition and mood in individuals with cognitive impairment no dementia (CIND) or Alzheimer’s disease (AD) a four month, randomised, double-blind, placebo controlled study was conducted. Fifty-seven participants with CIND and nineteen with AD were randomised to receive either omega-3 PUFAs (600 mg EPA and 625 mg DHA per day) or placebo (olive oil) over a four month period. Elevating depleted levels of EPA and DHA through supplementation in individuals with CIND or AD was found to have negligible beneficial effect on their cognition or mood. These findings confirm an overall negligible benefit of omega-3 PUFA supplementation for those with cognitive impairment and dementia. More intervention studies need to be undertaken with longer study durations and larger sample sizes. It may prove fruitful to examine effects of different doses as well as effects in other dementia subtypes.

Từ khóa


Tài liệu tham khảo

Lunn, 2006, The health effects of dietary unsaturated fatty acids, Nutr. Bull., 31, 178, 10.1111/j.1467-3010.2006.00571.x

Iso, 2001, Intake of fish and omega-3 fatty acids and risk of stroke in women, JAMA, 285, 304, 10.1001/jama.285.3.304

Virtanen, 2008, Fish consumption and risk of subclinical brain abnormalities on MRI in older adults, Neurology, 71, 439, 10.1212/01.wnl.0000324414.12665.b0

Hornstra, 2001, Influence of dietary fat type on arterial thrombosis tendency, J. Nutr. Health Aging, 5, 160

Harris, 2007, Cardiovascular benefits of omega-3 fatty acids, Cardiovasc. Res., 73, 310, 10.1016/j.cardiores.2006.08.019

Sydenham, 2012, Omega-3 fatty acid for the prevention of cognitive decline and dementia, Cochrane Database Syst. Rev., 13, 419

Vakhapova, 2010, Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: A double-blind placebo-controlled trial, Dement. Geriatr. Cogn. Disord., 29, 467, 10.1159/000310330

Otsuka, 2000, Analysis of dietary factors in Alzheimer’s disease: Clinical use of nutritional intervention for prevention and treatment of dementia, Nippon Ronen Igakkai Zasshi, 37, 970, 10.3143/geriatrics.37.970

Yehuda, 1996, Essential fatty acids preparation (SR-3) improves Alzheimer’s patients quality of life, Int. J. Neurosci., 87, 141, 10.3109/00207459609070833

Boston, 2004, Ethyl-EPA in Alzheimer’s disease—A pilot study, Prostaglandins Leukot. Essent. Fatty Acids, 71, 341, 10.1016/j.plefa.2004.07.001

Cederholm, 2006, Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: A randomized double-blind trial, Arch. Neurol., 63, 1402, 10.1001/archneur.63.10.1402

Basun, 2008, Omega-3 supplementation in mild to moderate Alzheimer’s disease: Effects on neuropsychiatric symptoms, Int. J. Geriatr. Psychiatry, 23, 161, 10.1002/gps.1857

Appleton, 2006, Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: Systematic review of published trials, Am. J. Clin. Nutr., 84, 1308, 10.1093/ajcn/84.6.1308

Kontani, 2006, Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction, Neurosci. Res., 56, 159, 10.1016/j.neures.2006.06.010

Chiu, 2008, The effects of Omega-3 fatty acids monotherapy in Alzheimer’s Disease and Mild Cognitive Impairment: A preliminary randomized double blind placebo controlled study, Prog. Neuro-Psychopharmacol., 32, 1538, 10.1016/j.pnpbp.2008.05.015

Dangour, 2010, Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: A randomized, double-blind, controlled trial, Am. J. Clin. Nutr., 91, 1725, 10.3945/ajcn.2009.29121

Geleijnse, 2008, Effects of fish-oil supplementation on mental well-being in older subjects: A randomised, double-blind, placebo-controlled trial, Am. J. Clin. Nutr., 88, 706, 10.1093/ajcn/88.3.706

Geleijnse, 2008, Effect of fish oil on cognitive performance in older subjects, Neurology, 71, 430, 10.1212/01.wnl.0000324268.45138.86

Geleijnse, 2012, Effects of n-3 fatty acids on cognitive decline: A randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimers Dement., 8, 278, 10.1016/j.jalz.2011.06.002

Nelson, H.E., and Willison, J.R. (1991). National Adult Reading Test (NART). Test Manual Including New Data Supplement, NFER-NELSON.

Terano, 1999, Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases, Lipids, 34, S345, 10.1007/BF02562338

Grosso, 2014, Role of omega-3 fatty acids in the treatment of depressive disorders: A comprehensive meta-analysis of randomized clinical trials, PLoS ONE, 9, e96905, 10.1371/journal.pone.0096905

Browning, 2012, Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish, Am. J. Clin. Nutr., 96, 748, 10.3945/ajcn.112.041343

Bascoul, C. (2007). Cardiff University. Unpublished conference poster.

Newman, 2000, Alzheimer’s disease revisited, Med. Hypotheses, 54, 774, 10.1054/mehy.1999.0948

Ruitenberg, 2001, Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease, N. Engl. J. Med., 345, 1515, 10.1056/NEJMoa010178

Phillips, 2012, Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparision of individuals with and without cognitive impairment and Alzheimer’s disease, Nutr. Neurosci., 15, 271, 10.1179/1476830512Y.0000000026

Simopoulos, 2002, The importance of the ratio of omega-6/omega-3 essential fatty acids, Biomed. Pharmacother., 56, 365, 10.1016/S0753-3322(02)00253-6

Simopoulos, 2002, Omega-3 Fatty acids in inflammation and autoimmune diseases, J. Am. Coll. Nutr., 21, 495, 10.1080/07315724.2002.10719248

Pedrosa, 2010, Functional evaluation distinguishes MCI patients from healthy elderly people—The ADCS/MCI/ADL scale, J. Nutr. Health Aging, 14, 703, 10.1007/s12603-010-0102-1

McKhann, 1984, Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group* under the auspoces of department of health and human services task force on Alzheimer’s disease, Neurology, 34, 939, 10.1212/WNL.34.7.939

Levy, 1994, Aging associated cognitive decline, Int. Psychogeriatr., 6, 63, 10.1017/S1041610294001626

Petersen, 2004, Mild cognitive impairment as a diagnostic entity, Intern. Med., 256, 183

Fisk, H.L., West, A.L., Childs, C.E., Burdge, G.C., and Calder, P.C. (2014). The use of gas chromatography to analyze compositional changes of fatty acids in rat liver tissue during pregnancy. J. Vis. Exp.

Folstein, 1975, “Mini-mental State”: A practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6

Brandt, 1991, The Hopkins Verbal Learning Test: Development of a new memory test with six equivalent forms, Clin. Neuropsychol., 5, 125, 10.1080/13854049108403297

Adshead, 1992, BASDEC: A novel screening instrument for depression in elderly medical in-patients, Br. Med. J., 305, 397, 10.1136/bmj.305.6850.397

Royall, 1998, CLOX: An executive clock drawing task, J. Neurol. Neurosur. Psychiatry, 64, 588, 10.1136/jnnp.64.5.588

Kaplan, E., Goodglass, H., and Weintraub, S. (2001). Boston Naming Test, Lippincott Williams and Wilkins. [2nd ed.].

Wechsler, A. (1999). Wechsler Adult Intelligence Scale, Pearson Publisher. [3rd ed.].

Wilson, B.A., Clare, L., Baddeley, A., Cockburn, J., Watson, P., and Tate, R. (1998). The Rivermead Behavioural Memory Test—Extended Version, Thames valley Test Company.

Bucks, 1996, Assessment of activities of daily living in dementia: Development of the Bristol activities of daily living scale, Age Ageing, 25, 113, 10.1093/ageing/25.2.113

Thông tin
Thông tin xuất bản

International Journal of Molecular Sciences

Tập 16 Số 10

24600-24613

Thông tin tác giả